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Abstract 
Artificial intelligence (AI) classification holds promise as a novel and affordable screening tool for 
clinical management of ocular diseases.  Rural and underserved areas, which suffer from lack of access to 
experienced ophthalmologists may particularly benefit from this technology. Quantitative optical 
coherence tomography angiography (OCTA) imaging provides excellent capability to identify subtle 
vascular distortions, which are useful for classifying retinovascular diseases. However, application of AI 
for differentiation and classification of multiple eye diseases is not yet established. In this study, we 
demonstrate supervised machine learning based multi-task OCTA classification.  We sought 1) to 
differentiate normal from diseased ocular conditions, 2) to differentiate different ocular disease conditions 
from each other, and 3) to stage the severity of each ocular condition. Quantitative OCTA features, 
including blood vessel tortuosity (BVT), blood vascular caliber (BVC), vessel perimeter index (VPI), 
blood vessel density (BVD), foveal avascular zone (FAZ) area (FAZ-A), and FAZ contour irregularity 
(FAZ-CI) were fully automatically extracted from the OCTA images. A stepwise backward elimination 
approach was employed to identify sensitive OCTA features and optimal-feature-combinations for the 
multi-task classification. For proof-of-concept demonstration, diabetic retinopathy (DR) and sickle cell 
retinopathy (SCR) were used to validate the supervised machine leaning classifier. The presented AI 
classification methodology is applicable and can be readily extended to other ocular diseases, holding 
promise to enable a mass-screening platform for clinical deployment and telemedicine. 
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Machine learning based artificial intelligence (AI) technology has garnered increasing interest in medical 
applications over the past few years.
1
  An AI-based diagnosis tool is designed to mimic the perception of 
the human brain for information processing and making objective decisions. Recent studies have 
demonstrated AI applications in detecting retinal disease progression,
2-5
 identifying malignant or benign 
melanoma,
6
 and classifying pulmonary tuberculosis
7
. In ophthalmic research, application of  AI 
technology have led to excellent diagnostic accuracy for several ocular conditions  such as diabetic 
retinopathy (DR), age related macular degeneration (AMD), and sickle cell retinopathy (SCR).
2, 4, 8-10
   
 In the current clinical setting, mass screening programs for common ocular conditions such as DR or 
SCR are heavily dependent upon experienced physicians to examine and evaluate retinal photographs. 
This process is time consuming and expensive, making it difficult to scale up to incorporate the millions 
of individuals, who harbor systematic diseases which are prone to affect the retina. Patients with early 
onset of retinopathies such as DR or SCR are initially asymptomatic yet require monitoring to ensure 
prompt medical interventions to prevent vision losses. However, it is not feasible to screen 65 million 
people in the USA over the age of 50 years,
1
 to identify for individuals with  signs of early retinopathy 
(AMD, DR or other disease). An AI-based diagnostic tool with capability for multiple-disease 
differentiation would have tremendous potential to advance mass-level screening of eye diseases.
11
  
 To date, most of the reported studies of AI diagnostic systems in literature are based on color fundus 
photography.
12-15
 Fundus photography is one of the most common clinical imaging modalities and has 
been widely used in evaluating retinal abnormalities. Supervised and unsupervised machine learning 
based diagnostic systems using fundus images have been developed by researchers for staging of 
individual retinopathies as well as to identify multiple ocular diseases.
8, 16-19
 However, these demonstrated 
AI-based diagnostic tools generally face two major challenges. Firstly, fundus images provide limited 
resolution and retinal vascular information, limiting its capability to quantify subtle micro-vascular 
distortions near the foveal area and in different retinal layers. Thus, diagnostic systems using supervised 
machine learning algorithms suffer from low-performing quantitative feature analysis and concurrently 
low diagnostic accuracy. Secondly, systems using unsupervised or deep machine learning require a large 
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and well documented database (ranging from 100,000 to millions) for training and optimizing 
convolutional neural networks. Even if an AI system is successfully trained, the intrinsic variance among 
different database from multiple imaging centers makes it extremely difficult to provide robust accuracy 
metrics. Additionally, in case of new retinal imaging modalities such as OCTA, it is quite challenging to 
accumulate large, multi-center database for efficient clinical deployment of AI-based diagnostic tools.         
As a potential solution to overcome these challenges, we propose a supervised machine learning based 
approach to train and evaluate a support vector machine (SVM) classifier model with quantitative optical 
coherence tomography (OCT) angiography (OCTA) features for multi-task AI classification of 
retinopathies. By providing excellent capability for depth-resolved visualization of retinal vascular 
plexuses, quantitative OCTA holds genuine promise for AI screening of retinopathies. Although the 
comparatively smaller data size of OCTA presently limits deep-learning based strategies, the sensitivity 
of OCTA features to detect onset and progression or retinopathies make it readily useful for supervised AI 
based screening. Recent studies have established several quantitative OCTA features correlated with 
subtle pathological and microvascular distortions in the retina. OCTA features such as blood vessel 
tortuosity (BVT), blood vascular caliber (BVC), vessel perimeter index (VPI), blood vessel density 
(BVD), foveal avascular zone (FAZ) area (FAZ-A), and FAZ contour irregularity (FAZ-CI) have also 
been validated  for objective classification and staging of DR
5, 20
 and SCR,
21
 individually. Our recent 
studies demonstrated that DR and SCR show different effects on OCTA features, and thus quantitative 
OCTA analysis promises the potential of multiple-task classification to differentiate retinopathies and 
stages. In this study, we propose to test the feasibility of using these quantitative OCTA features for 
machine leaning based multi-task AI screening of different retinopathies. For easy comparison with our 
recent studies, DR and SCR were selected as the two diseases for technical validation of the proposed AI 
screening methodology. The AI system containing a SVM classifier model utilizes a hierarchical 
backward elimination technique to identify optimal-feature-combination for the best diagnostic accuracy 
and most efficient classification performance. The AI-based screening tool performs multi-layer 
hierarchical tasks to perform 1) normal vs. disease classification, 2) inter-disease classification (DR vs. 
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SCR), and 3) staging of DR (mild, moderate and severe non-proliferative DR (NPDR)) and SCR (mild 
and severe).  The performance of the AI system has been quantitatively validated with manually labeled 
ground truth, using sensitivity, specificity and accuracy metrics along with graphical metrics, i.e., receiver 
operation characteristics (ROC) curve. 
Results 
The OCTA image database in this study included 115 images from 60 DR patients (20 mild, 20 medium 
and 20 severe NPDR), 90 images from 48 SCR patients (30 stage II mild and 18 stage III severe SCR), 
and 40 images from 20 control patients (representative images shown in supplementary Fig S1). Patient 
demographic data is shown in table 1. There were no statistical significances in age and sex distribution of 
between control, DR and SCR groups. (ANOVA, P = 0.14; chi-square test, P = 0.11 and P = 0.32, 
respectively). For DR, no significance in hypertension or insulin dependency between stages of disease 
groups was observed. 
Table 1. Demographics of control, DR and SCR subjects 
 Control DR SCR 
  Mild NPDR Moderate 
NPDR 
Severe 
NPDR 
Mild SCR  Severe SCR  
Number of subjects 20 20 20 20 30 18 
Sex (male) 12 11 12 11 17 11 
Age (mean ± SD) 42 ± 9.8 50.1 ± 12.61 50.8 ± 8.39 57.84 ± 10.37 51 ± 11.52 59.73 ± 
8.26 
Age range 25-71 24-74 32-68 41-73 28-71 46-75 
Duration of disease - 19.64±13.27 16.13±10.58 23.40 ± 11.95 13.25± 8.78 18.43±10.7 
Diabetes type - Type II Type II Type II - - 
Insulin 
dependent(Y/N) 
- 7/13 12/8 15/5 - - 
HbA1C, % - 6. 5 ± 0.6 7.3 ± 0.9 7.8 ± 1.3 - - 
HTN prevalence, % 10 45 80 80 - - 
a
 DR, diabetic retinopathy, SD, standard deviation, HbA1C, Glycated hemoglobin, HTN, hypertension 
Optimal feature selection using backward elimination  
We employ a logistic regression based model with backward elimination to select optimal combination of 
features for the multi-task classification. A summary of the quantitative univariate analysis of the OCTA 
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features is shown in supplementary Table S1-S3 for comparing control vs. DR vs. SCR, NPDR stages and 
SCR stages respectively. In general, BVT, BVC and FAZ parameters increased with disease onset and 
progression whereas BVD and VPI decreased. The comparison of the diagnostic accuracy for each feature 
in the backward elimination process is shown in table 2. Figure 1 provides further support to the results 
shown in table 2, showing relative changes of OCTA features in different groups. Each panel corresponds 
to four classification tasks respectively. The backward elimination initially started with all OCTA features 
and eliminated features one by one based on the prediction accuracy of the fitted regression model. The 
feature selection method identified an optimal feature combination for each classification task, i.e. 
perifoveal BVDSC3 (SCP, circular area: > 4mm), FAZ-AS (SCP) and FAZ-CID  (DCP) for control vs. 
disease classification; BVTS (SCP), BVDSC3, FAZ-AS, and FAZ-CID  for DR vs. SCR classification; 
BVDSC3 and FAZ-AS for NPDR staging; and BVTS, BVDSC3, and FAZ-CIS (SCP) for SCR staging. From 
table 2, we can observe that the individual accuracy of the optimal features in each classification tasks 
were highest compared to the other features and the model fitted with the combination of these optimal 
features provided the best diagnostic accuracy. Also, from figure 1, we can see that the relative changes in 
each cohort can be only observed in the chosen optimal OCTA features.         
Multi-task classification 
The SVM classifier performs the classification tasks in a hierarchical manner.  To evaluate the diagnostic 
performance in each step or task, we measured the sensitivity and specificity task. For each task, the ROC 
curves were also drawn (Fig. 2) and AUCs were calculated. At the first step, the SVM identifies diseased 
patients from control subjects with 97.84% sensitivity and 96.88% specificity (AUC 0.98). After 
identifying the diseased patients, the classifier sorts them to two groups: DR and SCR with 95.01% 
sensitivity and 92.25% specificity (AUC.94). After sorting to corresponding retinopathies, the SVM 
conducted the condition staging classification: 92.18% sensitivity and 86.43% specificity for NPDR 
staging (mild vs. moderate vs. severe; AUC 0.96), and 93.19% sensitivity and 91.60% specificity for SCR 
staging (mild vs. severe; AUC 0.97). The sensitivity, specificity and AUC metrics are calculated for SVM 
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model trained with optimal feature combination.  Supplementary table S4 shows the performance metrics 
in further details. 
Table 2. Diagnostic accuracy measured during hierarchical backward elimination.  
Parameters Diagnostic accuracy (%) 
 Control vs. Disease DR vs. SCR NPDR Staging SCR Staging 
BVTS 81.75 81.64 71.26 89.15 
BVCS 79.88 75.59 78.51 71.92 
VPIS 76.49 76.83 78.39 65.46 
BVDSC1 72.11 53.14 62.02 55.19 
BVDSC2 80.02 77.98 75.83 74.98 
BVDSC3 89.01 83.49 82.67 83.67 
BVDDC1 69.35 52.17 64.30 58.02 
BVDDC2 78.53 75.83 78.54 76.20 
BVDDC3 80.69 70.28 77.13 65.59 
FAZ-AS 91.67 83.66 85.02 78.84 
FAZ-AD 88.48 80.09 80.46 76.11 
FAZ-CIS 88.74 81.57 79.34 80.95 
FAZ-CID 89.05 82.65 78.95 75.69 
Optimal feature 
combination 
97.45 94.32 89.60 93.11 
a Superscript S and D denote SCP and DCP respectively. In case of BVD, C1-C3 denote circular area 1,2 and 3 
respectively as shown in figure 5. 
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Figure 1: Normalized feature trends for different cohorts. (A) Change in Disease group (DR and SCR) compared to 
control. (B) Change in SCR compared to DR. (C) Change in moderate and severe NPDR compared to mild NPDR. 
(D) Change in severe SCR compared to mild SCR. Error bars represent standard deviation. 
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Figure 2. ROC curves illustrating classification performances of the prediction model using optimal combination of 
features. (A) Control vs disease classification. (B) DR vs. SCR classification. (C) NPDR staging. (D) SCR staging.  
Discussion  
We herein demonstrate the feasibility of a supervised machine learning based AI screening tool for 
multiple retinopathies using quantitative OCTA technology. In a hierarchical manner, this diagnostic tool 
can perform multiple tasks to classify i) control vs. disease, ii) DR vs. SCR, iii) different stages of NPDR 
and SCR, using quantitative features extracted from OCTA images. OCTA images can provide 
visualization of subtle microvascular structures in intraretinal layers which permits a comprehensive 
quantitative analysis of pathological changes due to systematic retinal diseases such as DR and SCR. 
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Morphological distortions such as impaired capillary perfusion, vessel tortuosity and overall changes in 
foveal size and complexity etc. were quantitatively measured and compared for identifying onset and 
progression of DR or SCR in diabetes and SCD patients respectively. The SVM classifier model 
demonstrated a robust diagnostic performance in all classification tasks. The classification model also 
utilized a back-elimination strategy for choosing an optimal combination of OCTA features for getting the 
best diagnostic performance with highest efficiency. Proper implementation of this AI-based tool in 
primary care centers would facilitate a quick and efficient way of screening and diagnosis of vision 
impairment due to systematic diseases.  
For any screening and diagnostic prediction system, sensitivity is a patient safety criterion.
22
 The AI-
based tool’s major role is to identify patients prone to vision impairment due to retinopathies. In the 
control vs disease classification task, 94.84% sensitivity of our system represents the capability to identify 
individual eyes with retinopathies (DR and SCR) from a general pool of control, DR and SCR eyes. 
Furthermore, the system can identify patients with DR or SCR with 95.01% sensitivity. This is crucial for 
screening purposes, as those patients should be referred to eye care specialists. Similarly, specificity is 
also an important factor because it will represent the capability of detecting subjects that don’t require 
referral to an eye care specialist. When the data pool equals millions of patients, this discriminatory 
capability is crucial for efficient clinical effectiveness in mass-screening. Our system demonstrates 
96.88% specificity which means the control subjects would rarely be erroneously referred for treatment of 
retinopathies; additionally, 92.25% specificity in DR vs. SCR classification means the patients with DR 
or SCR would not be referred with an incorrect diagnosis. This is relevant since certain advanced stages 
of a disease tend to progress faster than others and hence require more expedient evaluation and 
management upon referral. In mass-screening applications, the AI classification tool will be useful to 
identify proper referral for patients with systematic diseases (i.e. diabetes or SCD) and avoid unnecessary 
referral for patients who don’t need specialized care at that time point. 
Our study demonstrated that an optimal combination of OCTA features can achieve maximum 
diagnostic accuracy for all classification tasks. As supported by results from table 2 and figure 1, we can 
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observe that, in all performance metrics, the classification model trained with optimal feature combination 
demonstrated better diagnostic proficiency compared to the model trained with individual features or 
combination of all features. The OCTA features analyzed in this study represent vascular and foveal 
distortions in retina due to retinopathy from both superficial and deep layers as well as localized circular 
regions in the retina (BVD). Out of all these OCTA features, the feature selection strategy identified the 
most sensitive features for each classification tasks to significantly distinguish different cohorts.] The 
high diagnostic accuracy of SVM classifier trained with optimal feature combination highlights the 
importance of the most relevant feature selection in automated classification. Few features that showed 
significance in the univariate analysis (Supplementary tables) were not selected in the final set of optimal 
features. This suggests a contrast between clinical applicability and overall difference of OCTA features 
among different patient groups. Ashraf et. al.
20
 observed a similar phenomenon when using feature 
selection for automated staging of DR eyes. In all the classification tasks, the most sensitive features also 
had low correlation amongst themselves. Figure 3 illustrates a scatter plot showing correlation analysis 
for DR vs. SCR classification. We can observe that only FAZ parameters had positive correlation with 
each other; BVT and BVD both were not significantly correlated with FAZ parameters (Spearman’s rank 
test, P>0.05), suggesting that all the features provided different pathological aspects of the diseased 
retina. Therefore, the four optimal features were objective for identifying DR or SCR associated 
distortions and their combination yielded strong classification performance.   
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Figure 3. Correlation analysis among four most sensitive features. The scatter plot also shows the distribution of 
control, DR and SCT patient data for different feature combination. 
The optimal OCTA features selected by the AI classification tool have been previously shown in the 
literature to be useful in quantitative analysis studies..
23-33
 Both BVD and FAZ parameters (FAZ-A and 
FAZ-CI) have been shown to be significant in identifying DR stages.
20, 31, 33, 34
  BVT is also an established 
predictor for SCR progression. In two separate studies, we previously demonstrated an SVM classifier for 
automated staging of DR groups (mild, moderate, severe)
5
 and SCR groups (stage II and III).
21
 In our DR 
study, the most sensitive OCTA feature was observed to be BVD while for SCR, it was BVT and FAZ. 
These sensitive OCTA features are also selected to be included in the optimal feature set by the backward 
elimination technique in our current study for different classification tasks. Our current study, therefore, 
supports our previous findings and also demonstrates the clinical importance of identifying most sensitive 
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features for different retinopathies. Furthermore, the optimal features included measurements from both 
SCP and DCP. Previous OCTA studies
20
 including our recent studies
5, 35
 have suggested that the onset and 
progression of DR or SCR in diabetes or SCD patients affect both the retinal layers. By choosing 
optimized features from SCP and DCP, the AI-based model ensured representation of layer specific 
distortions due to retinopathies.   
For practical implementation of any AI-based tool in mass-screening at a clinical setting, a major 
challenge is the computation time required for overall feature extraction, optimization and diagnostic 
prediction. Our AI-based screening tool required only 4-6 seconds to extract features from each OCTA 
image. From the training data, the optimized features are chosen using back elimination which takes 
approximate 40-50 seconds (done only one time) depending on the size of the dataset. After the training 
of the SVM classifier is completed, it takes 8-10 seconds for classifying the testing database used in this 
study. If new data is included for diagnosis prediction, it takes only 1-2 seconds per OCTA image to use 
the trained model to classify control, DR or SCR eyes. However, at this point the AI-based tool is 
implemented in MATLAB (Mathworks, Natick, MA, USA), a separate software not integrated in the 
OCTA imaging device (Angiovue from Optovue, Fremont, CA, in our case). Once the technology is 
integrated into the interface of the OCTA device, the users can view real-time prediction as soon as the 
OCTA image is captured in retina clinics. The diagnostic accuracy can be enhanced even further if the 
patient history or clinical information is integrated into the screening tool. 
Limitations of this study include relatively modest sample size for each of cohort and single imaging 
center. In future studies, we plan to include multiple imaging centers and a much larger OCTA database 
to test the robustness of our AI screening tool for practical implementation in retina clinics. Furthermore, 
we relied on the segmentation provided by the clinical device to identify the images from SCP and DCP. 
Thus, there is a possibility of segmentation error. The potential motion, projection artifacts in OCTA and 
error in reconstruction of OCTAs from SD-OCT volume data were few other limitations. However, we 
attempted to minimize the effect of these errors and artifacts in our study by excluding the images with 
severe artifacts, segmentation errors and patients with macular edema.  
 14 
In conclusion, we present a supervised machine learning based multi-task AI classification tool that 
uses an optimal combination of quantitative OCTA features for objective classification of control, DR and 
SCR eyes with excellent diagnostic accuracy. Using the feature selection strategy, the classifier selected 
BVDSC3, FAZ-AS and FAZ-CID for control vs. disease classification; BVTS , BVDSC3, FAZ-AS, and FAZ-
CID  for DR vs. SCR classification; BVDSC3 and FAZ-AS for staging of NPDR severity; and BVTS, 
BVDSC3, and FAZ-CIS for staging of SCR severity . The optimal-feature-combination directly correlates 
to the most significant morphological changes in retina for each classification tasks and provides the most 
effective classification performance with least computational complexity. Our diagnostic tool performs 
well with cross-validate data. However, further validation studies using larger cohorts of OCTA data from 
different centers and devices will facilitate future clinical implementation of a mass-level AI-based 
screening tool. 
Methods 
Figure 4 illustrates the step by step methodology for the machine learning based multi-task AI 
classification. Each classification task involves primarily three steps. The first step is OCTA image data 
acquisition and feature extraction (DA&FE). The second step is optimal feature identification (OFI) using 
a hierarchical backward elimination technique for the specific classification task. The third step is to 
validate multiple-task classification (MTC) using the identified optimal-feature-combinations.  
Data Acquisition and feature extraction 
OCTA data acquisition: This cross-sectional study was approved by the Institutional Review Board 
(IRB) of the University of Illinois at Chicago (UIC) and complied with the ethical standards stated in the 
Declaration of Helsinki. Both the DR and SCR patients were recruited from UIC Retinal Clinic. All 
patients underwent complete anterior and dilated posterior segment examination (JIL, RVPC). For DR, a 
retrospective study of consecutive type II diabetes patients was conducted who underwent OCT/OCTA 
imaging. The patients are representative of a university population of diabetic patients who require 
imaging for management of diabetic macular edema and DR.  Two board-certified retina specialists 
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classified the patients based on the severity of DR (mild, moderate, severe NPDR) according to the Early 
Treatment Diabetic Retinopathy Study (ETDRS) staging system. In case of SCR, disease stages were 
graded according to the Goldberg classification (stage I-V, from mild to severe). Only stage II (mild) and 
III (severe) SCR data were included in this study as stage I OCTA data were limited in number while 
stage IV OCTA images were unreliable due to distortions caused by hemorrhages and vessel 
proliferation. For simplification in the classification process, we define the stage II and III as mild and 
severe stage SCR, respectively. The control OCTA data were obtained from healthy volunteers who gave 
informed consent for OCT/OCTA imaging. Both eyes (OD and OS) were examined and imaged. We did 
not include eyes with other ocular disease or any pathological features in their retina such as epiretinal 
membranes and macular edema. Additional exclusion criteria included eyes with prior history of 
vitreoretinal surgery, intravitreal injections or significant (greater than a typical blot hemorrhage) macular 
hemorrhages.  
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Figure 4: (A) Step by step methodology of AIbased classification. (B) Optimal feature selection with hierarchical 
backward elimination technique. DA&FE: Data acquisition and feature extraction; OFI: Optimal feature 
identification; MTC: Multiple-task classification. 
SD-OCT and OCTA image data were acquired using an Angiovue SD-OCT device (Optovue, 
Fremont, CA, USA), consisting of a 70,000 Hz A-scan rate, and axial and lateral resolutions of ∼5 μm 
and ~15 μm, respectively. All OCTA images used in this study were 6 mm×6 mm scans; OCTA images 
were acquired from both superficial and deep capillary plexuses (SCP and DCP). All the images were 
qualitatively examined, OCTA images with severe motion or shadow artifacts were also excluded. The 
OCTA images were exported from imaging device and custom-developed MATLAB procedures were 
used for image processing, feature extraction and classification as described below. 
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OCTA pre-processing and feature extraction: All the OCTA images used in this study had a field of 
view (FOV) of 6 mm × 6 mm (304×304 pixels). The OCTA images were normalized to a standard 
window level based on the maximum and minimum intensity values to account for light and contrast 
image variation. Bias field correction and contrast adjustment of the OCTA images improved the overall 
reliability of the extracted features and concurrently the performance of classifier model to identify 
OCTAs from different cohorts.    
Six different quantitative OCTA features were extracted from each OCTA image (Fig. 5) for the AI 
classification. The vascular features were BVT, BVC, VPI, and BVD, while the foveal features were 
FAZ-A and FAZ-CI.  Before measuring the vascular features, the vessel map and skeleton map were 
extracted from the OCTA image (Fig 5B and 5C). For the vessel map, we have used a Hessian based 
multi-scale Frangi filter
36
 to enhance vascular flow information. This method utilizes the Eigen vectors of 
the Hessian matrices and calculates the likeliness of an OCTA region to be vascular structures. Adaptive 
thresholding along with morphological functions were furthers used for cleaning the vessel map and 
removing noises. From the vessel map, a skeleton map is generated using morphological shrinking 
functions. The extracted vessel and skeleton maps from OCTA images had an average area of 47.34% and 
25.81% respectively.  
A brief description of the feature measurement procedure is as follows: 
BVT: The BVT was measured in the SCP. For BVT measurement, the BVT of each vessel branch is 
measured from the skeleton map and average BVT is measured as, 
BVT =
1
n
∑ (
Geodesic distance  of a vessel branch i
Euclidean distance of a vessel branch i
)
n
i=1
                                                       (1) 
Euclidean distance =  √(x1 − x2)2 + (y1 − y2)2                                                     (2) 
 
Geodesic distance =  ∫ √ (
dx(t)
dt
)
2
 +  (
dy(t)
dt
)
2
 dt
t1
t0
                                                     (3) 
 
where [xi,yi] are the two endpoints of a vessel branch .  
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Figure 5. Representative OCTA images for illustrating the feature extraction. (A) Original OCTA image from a 
severe NPDR patient. (B) Segmented blood vessel map including large blood vessels and small capillaries. Hessian 
based Frangi vesselness filter and FD classification provide a robust and accurate blood vessel map. (C) Blood 
vessel skeleton map (red) with segmented fovea (marked blue region) and FAZ contour (green boundary marked 
around fovea). A random vessel branch is highlighted in green with X and Y endpoints identified in yellow dot. (D) 
Vessel perimeter map. (E) Fractal contour maps for blood vessel density measurement. Scale bar shown in A applies 
to all the images.  
BVC: BVC was measured from the SCP as the ratio of vascular area (calculated from vessel map) and 
vascular length (calculated from skeleton map),  
               BVC =
Vascular area
Vascular length
                                                               (4) 
VPI: VPI was measured from the perimeter map (Fig. 5D) in SCP as the ratio of vessel perimeter area 
and total image area, 
               VPI =
Perimeter area
Total image area
                                                               (5) 
BVD: BVD was measured in both SCP and DCP using fractal dimension (FD) technique. The details and 
rationale about FD calculation is previously described.
35
 Each pixel is assigned an FD value from 0 to 1 
where 0 corresponds to avascular region and 1 corresponds to large vessel pixels. The FD of 0.7 to 
1corresponds to vessel pixels and average BVD is measured as the vascular area to total image area. 
               BVD =
Vascular area
Total image area
                                                               (6) 
BVD the measurements were taken in three localized regions in the retina, three circular regions of 
diameter 2 mm, 4 mm and 6 mm (C1, C2, and C3) around the fovea (as shown in Fig.5E). The segmented 
FAZ area was excluded when measuring BVD for improved diagnostic accuracy.  
FAZ-A: The FAZ-A was measure in both SCP and DCP. The fovea was demarcated automatically (blue 
area in Fig. 5C)
35
 and FAZ-A was measured as, 
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       FAZ − A (µm2) = Number of pixels is Fovea × Area of single pixel                  (6) 
The automatically segmented FAZ area was compared to manually traced FAZ labelling and had 98.26% 
similarity with manually segmented ground truths.  
FAZ-CI: FAZ-CI was measured in both SCP and DCP. From the demarcated fovea, FAZ contour was 
segmented automatically
35
 (green demarcated contour in Fig.5C). From the segmented contour the FAZ-
CI was measured as, 
      FAZ − CI =
Perimeter of the FAZ contour 
Perimeter of a circle with equivalant area to the FAZ
                            (5) 
Optimal feature identification 
Statistics and classification model: Statistical analyses were conducted using MATLAB (Mathworks, 
Natick, MA, USA) and OriginPro (OriginLab Corporation, MA, USA). All the OCTA features were 
tested for normality using a Shapiro-Wilk test. For normally distributed variables, one versus one 
comparisons were conducted using Student’s t-test and one way, multi-label analysis of variance 
(ANOVA) was used to compare differences among multiple groups. If the features were not normally 
distributed, we used independent sample t-test (Mann-Whitney) for one versus one comparisons and non-
parametric Kruskal-Wallis test for comparing multiple groups. Chi-square test was used to compare the 
sex and hypertension distribution among different groups. For age distribution, we used ANOVA. 
Spearman’s correlation coefficients (rs) were measured to analyze the relationship among the OCTA 
features and their correlation with DR or SCR severity. Statistical significance for univariate analysis and 
correlation test was defined with P < 0.05; however, the P values were Bonferroni-corrected for multiple 
simultaneous group comparisons. For the classification model that would be trained with OCTA features 
and perform the diagnosis prediction, we chose a support vector machine (SVM) classifier. In case of 
logistic regression based backward elimination (Fig. 4B), the initial critical value of P was 0.15 for the 
univariate model while it was 0.1 for multi-variate model. In this case, a P value of 0.05 or less is too 
conservative and there might be a possibility of losing valuable information from multivariate regression 
analysis of different features.  
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Optimal feature selection with backward elimination: We implemented feature optimization to choose a 
subset of OCTA features that delivers the best diagnostic prediction for each classification tasks, i.e. 1) 
identifying disease patients from control, 2) inter-disease (DR vs. SCR) classification and 3) Staging of 
DR (mild, moderate, and severe NPDR) and SCR (mild and severe) respectively. Taking inspiration from 
Occam’s Razor, we aim to choose the smallest classification model that fits the data. For choosing this 
optimal feature combination for each classification task, we used a stepwise backward elimination 
technique. The flowchart of necessary steps taken in backward elimination of features is illustrated in the 
Fig.4B. Backward elimination starts with all of the predictors in the model. The variable that is least 
significant--that is, the one with the largest P value with worst prediction performance in a regression 
analysis is removed and the model is refitted. Each subsequent step removes the least significant variable 
in the model until all remaining variables have individual P values smaller than critical P value (set at 
0.05). After the SVM is trained with the optimal feature combination, we tested the classification model 
with a testing data set. This feature selection process using backward elimination is repeated for each of 
the steps and the SVM model is trained with corresponding optimal feature combination at each step for a 
specific classification task. For control vs. disease and DR. vs. SCR classification, the SVM performs a 
binary (one vs one) classification while for staging disease conditions (mild vs. moderate vs. severe 
NPDR and mild vs. severe SCR) the SVM performs a multi-class classification. The prediction is 
performed on the testing database with 5-fold cross validation to control any overfitting. Once the SVM is 
trained with optimal feature combination, any new data can be directly inputted into the classifier to 
generate task-specific predictions. 
Performance metrics: The performance of the prediction model was evaluated with sensitivity, 
specificity, and accuracy metrics. ROC (Receiver Operation Characteristics) curves were also generated 
along with area under the ROC curve (AUC). ROC curve plots the true positive rate (i.e., sensitivity) as a 
function of false positive rate (i.e., 1-specificity) at different tradeoff points. AUC is measured to quantify 
how well the classifier is able to identify the different classes. The closer the curve to the left up corner, 
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the more accuracy the prediction is. AUC equals 1 or 100% represents a perfect prediction, and 0.5 or 
50% represents a bad prediction.  
 
Data and materials availability 
The datasets generated during the current study that were used to calculate the primary outcome 
parameters are available upon reasonable request from the corresponding author, X.Y. 
Code availability 
The AI system described in this study is an SVM model, which is already established classifier model. 
The feature extraction codes have been previously described in our published articles. However, they 
can be made available upon reasonable request form X.Y. 
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Supplementary materials 
 
Figure S1. Representative OCTA images for illustrating the feature extraction. (A1-A5) Control subject, (B1-B5) Mild NPDR 
subject, (C1-C5) Moderate NPDR subject, (D1-D5) Severe NPDR subject, (E1-E5) Mild SCR (stage II) subject, (F1-F5) Severe 
SCR subject. (Column 1) OCTA image. (Column 2) Segmented blood vessel map including large blood vessels and small 
capillaries. Hessian based Frangi vesselness filter and FD classification provide a robust and accurate blood vessel map. (Column 
3) Skeletonized blood vessel map (red) with segmented FAZ (marked green region) and FAZ contour (yellow boundary marked 
around FAZ). (Column 4) Vessel perimeter map. (Column 5) Contour maps created with normalized values of local fractal 
dimension. Scale bar shown in A1 corresponds to 1.5 mm and applies to all the images. 
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Univariate analysis 
 
Table S1. Univariate analysis of individual OCTA features for control, DR and SCR cohorts. 
 Control DR SCR P values 
Control  
vs. DR 
Control  
vs. SCR 
DR  
vs. SCR 
BVT (SCP) 1.11 ± 0.07 1.18 ± 0.04 1.25 ± 0.08 0.016 <0.001 0.022 
BVC (μm)(SCP) 17.47 ± 1.9 20.32 ± 3.8 21.43 ± 2.4 0.024 0.019 0.836 
VPI (SCP) 10.26 ± 1.32 8.76 ± 2.60 8.43 ± 0.79 0.012 0.036 0.325 
BVD (%)       
C1 (SCP), 2mm 40.16 ± 10.32 35.61 ± 8.11 36.08 ± 7.02 0.019 0.051 0.154 
C2 (SCP), 4mm 47.53 ± 6.32 40.72 ± 4.17 44.24 ± 5.52 <0.001 <0.001 0.017 
C3 (SCP), 6mm 47.96 ± 2.36 38.89 ± 3.31 42.84 ± 3.24 <0.001 <0.001 0.014 
C1 (DCP), 2mm 42.72 ± 13.19 38.98 ± 6.09 40.28 ± 10.17 0.024 0.058 0.208 
C2 (DCP), 4mm 49.16 ± 5.78 43.32 ± 7.09 42.20 ± 4.17 <0.001 0.011 0.095 
C3 (DCP), 6mm 48.97 ± 3.18 41.75 ± 6.53 43.29 ± 4.30 <0.001 <0.001 0.005 
FAZ-A (SCP), mm2 0.30 ± 0.06 0.39 ± 0.04 0.43 ± 0.05 0.006 <0.001 0.008 
FAZ-A (DCP), mm2 0.39 ± 0.08 0.52 ± 0.06 0.54 ± 0.06 0.006 0.005 0.059 
FAZ-CI (SCP) 1.14 ± 0.11 1.38 ± 0.13 1.47 ± 0.14 <0.001 <0.001 0.004 
FAZ-CI (DCP) 1.18± 0.12 1. 41 ± 0.10 1.53 ± 0.13 <0.001 <0.001 0.002 
a
All values are presented as mean ± SD.  
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Table S2. Univariate analysis of individual OCTA features for NPDR stages.  
 
Mild 
NPDR 
Moderate 
NPDR 
Severe 
NPDR 
P values 
Mild vs. 
Moderate 
Moderate 
vs. Severe 
Severe  
vs. Mild 
BVT (SCP) 1.14 ± 0.05 1.17 ± 0.06 1.23± 0.04 0.260 0.546 0.017 
BVC (μm)(SCP) 18.06± 1.9 21.04 ± 2.2 21.86 ± 1.7 0.036 0.213 0.011 
VPI (SCP) 9.94 ± 0.38 8.56 ± 0.15 7.79 ± 0.21 0.025 0.044 <0.001 
BVD (%)       
C1 (SCP), 2mm 36.62± 9.03 36.01 ± 5.81 34.20 ± 9.38 0.019 0.154 0.041 
C2 (SCP), 4mm 44.36 ± 6.72 40.81 ± 5.22 36.98 ± 6.50 <0.001 <0.001 0.005 
C3 (SCP), 6mm 43.85 ± 3.38 38.95 ± 4.65 33.87 ± 4.24 <0.001 <0.001 0.014 
C1 (DCP), 2mm 40.88 ± 10.37 38.78 ± 7.01 37.29 ± 8.16 0.042 0.658 0.018 
C2 (DCP), 4mm 47.42 ± 4.83 43.39 ± 6.39 39.16 ± 7.25 <0.001 0.026 <0.001 
C3 (DCP), 6mm 41.75 ± 11.08 42.32 ± 7.45 37.73 ± 5.29 <0.001 0.006 <0.001 
FAZ-A (SCP), mm2 0.33 ± 0.05 0.38 ± 0.07 0.46 ± 0.06 <0.001 <0.001 <0.001 
FAZ-A (DCP), mm2 0.46 ± 0.07 0.53 ± 0.12 0.58 ± 0.09 0.018 0.003 <0.001 
FAZ-CI (SCP) 1.29 ± 0.14 1.38 ± 0.14 1.46 ± 0.18 <0.001 0.002 <0.001 
FAZ-CI (DCP) 1.31 ± 0.21 1.42 ± 0.19 1.49 ± 0.17 <0.001 0.009 0.002 
a
All values are presented as mean ± SD 
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Table S3. Univariate analysis of individual OCTA features for SCR stages.  
 
Mild SCR 
Severe 
SCR 
P values (Mild vs. severe) 
BVT (SCP) 1.22 ± 0.07 1.28± 0.05 <0.001 
BVC (μm)(SCP) 18.82 ± 3.1 24.05 ± 2.6 0.385 
VPI (SCP) 9.21 ± 0.26 9.64 ± 0.29 0.521 
BVD (%)    
C1 (SCP), 2mm 36.99 ± 6.13 35.16 ± 8.08 0.163 
C2 (SCP), 4mm 46.35 ± 4.53 42.13 ± 8.29 0.097 
C3 (SCP), 6mm 46.85 ± 6.29 38.83 ± 3.23 0.018 
C1 (DCP), 2mm 41.88 ± 10.85 38.68 ± 11.26 0.364 
C2 (DCP), 4mm 47.06 ± 7.89 37.4 ± 8.36 0.073 
C3 (DCP), 6mm 46.05 ± 6.25 40.5 ± 6.23 0.004 
FAZ-A (SCP), mm2 0.41 ± 0.19 0..45 ± 0.12 <0.001 
FAZ-A (DCP), mm2 0.52 ± 0.19 0.56 ± 0.17 <0.001 
FAZ-CI (SCP) 1.45 ± 0.12 1.50 ± 0.15 <0.001 
FAZ-CI (DCP) 1.50 ± 0.14 1.56 ± 0.16 0.002 
a
All values are presented as mean ± SD 
 
Classification performance 
 
Table S4. Performance evaluation of multi-task classification algorithm using optimal feature combination. 
Parameters Classification performance 
 
Area under the ROC 
curve, AUC  
Sensitivity (%) Specificity (%) 
Control vs. Disease 0.98 97.84 96.88 
DR vs. SCR 0.94 95.01 92.25 
NPDR Staging 0.96 92.18 86.43 
SCR Staging 0.97 93.19 91.60 
 
 
